Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide

European Journal of Cancer

Volumn 36, Issue 14, 2000, Pages 1788-1795

  Osoba, D ^a   Brada, M ^b   Yung, W K A ^c   Prados, M D ^d  

^a QOL Consulting   (Canada)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaplastic astrocytoma; Chemotherapy; Health related quality of life; Temozolomide; Tumour response

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL INTERACTION; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BRAIN NEOPLASMS; DACARBAZINE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0033898465     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00165-9     Document Type: Article

References (17)

1. Brada M, Yung WKA, Osoba D. Symptom burden in patients (PTS) with recurrent high-grade gliomas. Proc Am Soc Clin Oncol 1999, 18, 147a (abstract 564).
2. Yung W.K.A., Prados M.D., Yaya-Tur R.et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J. Clin. Oncol. 17:1999;2762-2771.
3. Osoba D., Aaronson N.K., Zee B., Sprangers M., te Velde A. Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. Qual. Life Res. 6:1997;103-108.
4. Osoba D., Aaronson N.K., Muller K.et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual. Life Res. 5:1996;139-150.
5. Osoba D., Aaronson N.K, . Muller M.et al. Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. J. Neuro-Oncol. 31:1997;263-278.
6. Aaronson N.K., Ahmedzai S., Bergman B.et al. The European Organization for Research and Treatment of Cancer QLQ-C30. a quality-of-life instrument for use in international trials in oncology J. Natl. Cancer Inst. 85:1993;365-376.
7. Osoba D., Zee B., Pater J., Warr D., Kaizer L., Latreille J. Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual. Life Res. 3:1994;353-364.
8. Ringdal G.I., Ringdal K. Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual. Life Res. 2:1993;129-140.
9. Niezgoda H.E., Pater J.L. A validation study of the domains of the core EORTC Quality of Life Questionnaire. Qual. Life Res. 2:1993;215-319.
10. Fayers P, Aaronson N, Bjordal K, Curran D, Groenvald M. EORTC QLQ-C30 Scoring Manual (2nd edn). Brussels, Quality of Life Unit, EORTC Data Centre, 1999.
11. Osoba D., Rodrigues G., Myles J., Zee B., Pater J. Interpreting the significance of changes in health-related quality-of-life-scores. J. Clin. Oncol. 16:1998;139-144.
12. King M.T. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual. Life Res. 5:1996;555-567.
13. Ware J.E., Kosinski M., Keller S.D. SF-36 Physical and Mental Health Summary Scales. A User's Manual:1994;The Health Institute, New England Medical Center, Boston.
14. Jaeschke R., Singer J., Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clin. Trials. 10:1989;407-415.
15. Juniper E.F., Guyatt G.H., Willan A.et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J. Clin. Epidemiol. 47:1994;81-87.
16. Kazis L.E., Anderson J.J., Meenan R.F. Effect sizes for interpreting changes in health status. Med. Care. 27(Suppl. 3):1989;S178.
17. Cohen J. Statistical Power Analysis for the Behavioural Sciences. 1997;Academic Press, New York. 8.